PHN.MI Stock - Pharmanutra S.p.A.
Unlock GoAI Insights for PHN.MI
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $116.15M | $101.03M | $83.39M | $68.14M | $58.48M |
| Gross Profit | $82.79M | $48.95M | $30.17M | $32.15M | $21.30M |
| Gross Margin | 71.3% | 48.4% | 36.2% | 47.2% | 36.4% |
| Operating Income | $27.37M | $23.36M | $23.04M | $18.69M | $13.22M |
| Net Income | $16.61M | $12.83M | $15.05M | $13.77M | $14.07M |
| Net Margin | 14.3% | 12.7% | 18.0% | 20.2% | 24.1% |
| EPS | $1.73 | $1.33 | $1.56 | $1.42 | $1.45 |
Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, rest of Europe, the Middle East, Far East, and internationally. The company also produces and markets pharmaceuticals, medical devices, OTC products, and nutraceuticals for pediatric sector; and produces and distributes raw materials and active ingredients for the food, pharmaceutical, and food supplement industries. Its products primarily include SiderAL, SiderAL Forte, SiderAL Folic, Cardio SiderAL, SiderAL Med, Cetilar Crema, Cetilar Patch, Tape, ApportAL, UltraMag, Gestalys DHA, Novomega, Bonecal, and DiKappa 2. The company distributes and sells its products through sales representatives, wholesalers, pharmacies, and para-pharmacies. Pharmanutra S.p.A. was founded in 2003 and is based in Pisa, Italy.
Visit WebsiteEarnings History & Surprises
PHN.MIEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Mar 10, 2026 | — | — | — | — |
Q4 2025 | Nov 10, 2025 | — | $0.51 | — | — |
Q2 2025 | May 12, 2025 | — | $0.25 | — | — |
Q1 2025 | Mar 14, 2025 | $0.54 | $0.36 | -33.1% | ✗ MISS |
Q4 2024 | Nov 11, 2024 | $0.43 | $0.44 | +2.3% | ✓ BEAT |
Q3 2024 | Jul 24, 2024 | $0.60 | $0.65 | +8.7% | ✓ BEAT |
Q2 2024 | May 14, 2024 | — | $0.27 | — | — |
Q1 2024 | Mar 15, 2024 | $0.40 | $0.32 | -20.0% | ✗ MISS |
Q4 2023 | Nov 6, 2023 | $0.27 | $0.26 | -3.7% | ✗ MISS |
Q3 2023 | Sep 11, 2023 | $0.45 | $0.19 | -57.8% | ✗ MISS |
Q2 2023 | May 8, 2023 | $0.44 | $0.56 | +27.3% | ✓ BEAT |
Q1 2023 | Mar 16, 2023 | $0.24 | $0.23 | -4.2% | ✗ MISS |
Q4 2022 | Nov 7, 2022 | $0.42 | $0.48 | +14.3% | ✓ BEAT |
Q3 2022 | Sep 5, 2022 | $2.48 | $0.49 | -80.2% | ✗ MISS |
Q2 2022 | May 9, 2022 | $0.31 | $0.36 | +16.1% | ✓ BEAT |
Q1 2022 | Mar 19, 2022 | $0.23 | $0.30 | +30.4% | ✓ BEAT |
Q4 2021 | Nov 9, 2021 | $0.26 | $0.39 | +50.0% | ✓ BEAT |
Q3 2021 | Sep 6, 2021 | $0.38 | $0.47 | +23.7% | ✓ BEAT |
Q2 2021 | May 10, 2021 | — | $0.26 | — | — |
Q1 2021 | Mar 22, 2021 | — | $0.18 | — | — |
Latest News
Frequently Asked Questions about PHN.MI
What is PHN.MI's current stock price?
What is the analyst price target for PHN.MI?
What sector is Pharmanutra S.p.A. in?
What is PHN.MI's market cap?
Does PHN.MI pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to PHN.MI for comparison